OSE — Ose Immunotherapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapContrarian

Annual balance sheet for Ose Immunotherapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	29.4	33.6	25.6	18.7	16.7
Net Total Accounts Receivable
Net Total Receivables	7.97	7.66	8.13	9.06	4.14
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39.8	44.2	37.2	30.5	69.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.79	5.44	4.98	4.07	3.42
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	97	102	91.8	82.1	124
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.1	16.8	16.3	18.8	20.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	35.6	54	59.1	59.1	60.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	61.4	47.9	32.7	23	63.8
Total Liabilities & Shareholders' Equity	97	102	91.8	82.1	124
Total Common Shares Outstanding